Article
Neutralizing antibodies in patients with chronic hepatitis C and correlation to liver cirrhosis and estimated duration of infection.
Journal of medical virology - 1 Oct 2016
Pedersen Jannie, Lundbo Lene Fogt, Krarup Henrik, Bukh Jens, Weis Nina
Abstract excerpt
Although chronic hepatitis C virus (HCV) infection accounts for 30% of individuals with cirrhotic livers worldwide, factors influencing disease progression are far from elucidated. The aim of this study was to determine whether the level of neutralizing antibodies (NAbs) correlated with the development of cirrhosis in patients with chronic HCV infection, genotype 1, when adjusting for estimated duration of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
